Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Trial of Revascularization With Solitaire Stentriever Versus Best Medical Therapy in the Treatment of Acute Ischemic Stroke Due to Basilar Artery Occlusion Presenting Within 6-24 Hours of Symptom Onset

NCT02737189 is registered in ClinicalTrials.gov with Xuanwu Hospital, Beijing as lead sponsor.

NCT NCT02737189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02737189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Trial of Revascularization With Solitaire Stentriever Versus Best Medical Therapy in the Treatment of Acute Ischemic Stroke Due to Basilar Artery Occlusion Presenting Within 6-24 Hours of Symptom Onset
Lead sponsor
Xuanwu Hospital, Beijing
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2016
Completion date
June 30, 2022
Enrollment
217 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

basilar artery occlusion, cerebrovascular disorders, ischemic stroke